U.S. Physical Therapy, Inc. (USPH) Receives Average Recommendation of “Buy” from Analysts
U.S. Physical Therapy, Inc. (NYSE:USPH) has received a consensus rating of “Buy” from the six research firms that are covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $75.25.
Several research analysts recently weighed in on the stock. Cantor Fitzgerald reissued a “buy” rating and set a $80.00 price objective on shares of U.S. Physical Therapy in a research note on Tuesday, January 9th. Zacks Investment Research raised shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $82.00 price objective on the stock in a research note on Saturday, January 6th. Barrington Research lowered shares of U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a research note on Friday, November 3rd. Finally, BidaskClub raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, October 25th.
In other U.S. Physical Therapy news, Director Mark J. Brookner sold 2,625 shares of U.S. Physical Therapy stock in a transaction that occurred on Wednesday, December 27th. The shares were sold at an average price of $71.23, for a total value of $186,978.75. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Lawrance W. Mcafee sold 2,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $68.68, for a total transaction of $137,360.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 10,875 shares of company stock worth $775,331. Insiders own 3.10% of the company’s stock.
U.S. Physical Therapy (USPH) traded up $2.60 during trading on Friday, reaching $74.90. 54,904 shares of the company traded hands, compared to its average volume of 46,736. U.S. Physical Therapy has a twelve month low of $56.50 and a twelve month high of $78.00. The company has a market cap of $917.17, a price-to-earnings ratio of 45.12, a price-to-earnings-growth ratio of 2.69 and a beta of 1.22. The company has a quick ratio of 2.04, a current ratio of 2.04 and a debt-to-equity ratio of 0.30.
ILLEGAL ACTIVITY NOTICE: “U.S. Physical Therapy, Inc. (USPH) Receives Average Recommendation of “Buy” from Analysts” was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be viewed at https://theolympiareport.com/2018/02/14/u-s-physical-therapy-inc-usph-receives-average-recommendation-of-buy-from-analysts.html.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.